KU-0063794

CatalogusnummerS1226 Batch:S122605

Afdrukken

Technische gegevens

Formule

C25H31N5O4

Moleculair gewicht 465.54 CAS-nr. 938440-64-3
Oplosbaarheid (25°C)* In vitro DMSO 20 mg/mL (42.96 mM)
Water Insoluble
Ethanol Insoluble
In vivo (Voeg oplosmiddelen afzonderlijk en in volgorde toe aan het product.)
Homogeneous suspension
CMC-NA
≥5mg/ml Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
Clear solution
30%PEG400 0.5%Tween80 5%propylene glycol

Gevalideerd door Selleck labs. Mocht u aanpassingen aan deze formulering nodig hebben, neem dan contact op met ons verkoopteam voor maatwerktesten.

30.000mg/ml (64.44mM) Taking the 1 mL working solution as an example, add 300 μL of 100 mg/ml clarified PEG400 stock solution to 5 μL of Tween80, mix evenly to clarify it; add 50 μL Propylene glycol to the above system, mix evenly to clarify it; then continue to add 645 μL ddH2O to adjust the volume. to 1 mL. The mixed solution should be used immediately for optimal results. 
* <1 mg/ml betekent licht oplosbaar of onoplosbaar.
* Houd er rekening mee dat Selleck de oplosbaarheid van alle verbindingen intern test en de werkelijke oplosbaarheid enigszins kan afwijken van gepubliceerde waarden. Dit is normaal en is te wijten aan lichte batch-tot-batch variaties.
* Verzending op kamertemperatuur (Stabiliteitstests tonen aan dat dit product zonder koelmaatregelen kan worden verzonden.)

Voorbereiden van stamoplossingen

Biologische activiteit

Beschrijving KU-0063794 is een potente en zeer specifieke dual-mTOR remmer van mTORC1 en mTORC2 met een IC50 van ~10 nM in celvrije assays; geen effect op PI3Ks.
Doelen
mTORC1
(Cell-free assay)
mTORC2
(Cell-free assay)
~10 nM ~10 nM
In vitro

Compared with the mTOR inhibitor PP242, KU-0063794 exhibits higher specificity for mTOR, as being inactive against PI3Ks or 76 other kinases. In HEK-293 cells, this compound at 30 nM is sufficient to rapidly ablate S6K1 activity by blocking the phosphorylation of the hydrophobic motif (Thr389) and subsequently the phosphorylation of the T-loop residue (Thr229). In case of IGF1 stimulation of serum-starved HEK-293 cells, 300 nM of this compound is needed to inhibit the S6K1 activity by ~90%. This chemical at 100-300 nM also completely inhibits the amino-acid-induced phosphorylation of S6K1 and S6 protein. Similar to S6K1, it inhibits the phosphorylation of mTORC1 at Ser2448 and mTORC2 at Ser2481 in a dose-dependent and time-dependent manner. In the presence of serum or following IGF1 stimulation, this compound induces a dose-dependent inhibition of the activity and phosphorylation of Akt at Ser473 and unexpected Thr308 as well as the phosphorylation of the Akt substrates PRAS40 at Thr246, GSK3α/GSK3β at Ser21/Ser9 and Foxo-1/3a at Thr24/Thr32. This compound but not rapamycin inhibits SGK1 activity and Ser422 phosphorylation as well as its physiological substrate NDGR1 in a dose-dependent manner, to the same extent as S6K1 and Akt phosphorylation, whereas it dose not inhibit phorbol ester induced ERK or RSK phosphorylation and RSK activation. Compared with rapamycin, this chemical exhibits more significant potency to induce the complete dephosphorylation of 4E-BP1 at Thr37, Thr46 and Ser65. It inhibits cell growth of both wild-type and mLST8-deficient MEFs and induces a G1 cell cycle arrest, more significantly than rapamycin.

In vivo

Ku0063794 inhibits tumor growth and mTOR signaling in a preclinical renal cell carcinoma model. However, this compound was not more effective in the animal study. A possible explanation for lack of greater activity in vivo for this chemical.

Protocol (uit referentie)

Kinase-assay:

[1]

  • mTOR-complexen kinase-assays

    HEK-293 cellen worden vers gelyseerd in Hepes lysisbuffer. Lysaat (1-4 mg) wordt voorgeklaard door incubatie met 5-20 μL Proteïne G-Sepharose geconjugeerd aan pre-immuun IgG. De lysaatextracten worden vervolgens geïncubeerd met 5-20 μL Proteïne G-Sepharose geconjugeerd aan 5-20 μg van ofwel anti-Rictor of anti-Raptor antilichaam, of pre-immuun IgG. Alle antilichamen zijn covalent geconjugeerd aan Proteïne G-Sepharose. Immunoprecipitaties worden gedurende 1 uur bij 4 °C uitgevoerd op een trilplatform. De immunoprecipitaten worden vier keer gewassen met Hepes lysisbuffer, gevolgd door twee wassingen met Hepes kinasebuffer. Voor Raptor-immunoprecipitaten die worden gebruikt voor het fosforyleren van S6K1, bevat de buffer voor de eerste twee wasstappen 0,5 M NaCl om optimale kinase-activiteit te garanderen. GST-Akt1 wordt geïsoleerd uit serum-deprived HEK-293 cellen geïncubeerd met PI-103 (1 μM gedurende 1 uur). GST-S6K1 wordt gezuiverd uit serum-deprived HEK-293 cellen geïncubeerd met rapamycine (0,1 μM gedurende 1 uur). mTOR-reacties worden geïnitieerd door toevoeging van 0,1 mM ATP en 10 mM MgCl2 in aanwezigheid van verschillende concentraties KU-0063794 en GST-Akt1 (0,5 μg) of GST-S6K1 (0,5 μg). De reacties worden gedurende 30 minuten bij 30 °C uitgevoerd op een trilplatform en gestopt door toevoeging van SDS-monsterbuffer. Reactiemengsels worden vervolgens gefilterd door een 0,22 μm poriegrootte Spin-X-filter en monsters worden onderworpen aan elektroforese en immunoblot-analyse met de aangegeven antilichamen.

Celassay:

[1]

  • Cellijnen

    Wild-type and mLST8 deficient MEFs

  • Concentraties

    Dissolved in DMSO, final concentration ~3 μM

  • Incubatietijd

    24, 48, and 72 hours

  • Methode

    Cells are treated with KU-0063794 for 24, 48, and 72 hours, and the medium is changed every 24 hours with freshly dissolved this compound. For the measurement of cell growth, cells are washed once with PBS, and fixed in 4% (v/v) paraformaldehyde in PBS for 15 minutes. After washing once with water, the cells are stained with 0.1% Crystal Violet in 10% ethanol for 20 minutes and washed three times with water. Crystal Violet is extracted from cells with 0.5 mL of 10% (v/v) ethanoic (acetic) acid for 20 minutes. The eluate is then diluted 1:10 in water and absorbance at 590 nm is quantified. For the assessment of cell cycle distribution, cells are harvested by trypsinization, washed once in PBS, and re-suspended in ice-cold aq. 70% (v/v) ethanol. Cells are washed twice in PBS plus 1% (w/v) BSA and stained for 20 minutes in PBS plus 0.1% (v/v) Triton X-100 containing 50 g/mL propidium iodide and 50 g/mL RNase A. The DNA content of cells is determined using a FACSCalibur flow cytometer and CellQuest software. Red fluorescence (585 nm) is acquired on a linear scale, and pulse width analysis is used to exclude doublets. Cell-cycle distribution is determined using FlowJo software.

Dierstudie:

[2]

  • Dierlijke modellen

    Nu/Nu nude mice

  • Doseringen

    8 mg/kg

  • Toediening

    i.p.

Referenties

  • https://pubmed.ncbi.nlm.nih.gov/19402821/
  • https://pubmed.ncbi.nlm.nih.gov/23349989/

Klantproductvalidatie

Effects of PI3K and mTOR inhibitors on IGF1R and AKT signaling in RMS cells. Rh41 cells were treated with 0.3 uM PI3K inhibitor BKM120, 0.3 uM mTOR inhibitor KU0063794 for the indicated time. Lysates were made and analyzed for p-AKT, S6RP and IGF1R.

Gegevens van [ Oncogene , 2013 , 10.1038/onc.2013.509 ]

<p> </p><p>mTORC2 is required for mechanical activation of Akt. A, immunoblots of mdMSC subjected to strain for 45 min following treatment with the mTOR inhibitor KU0063794 (2uM). B, densitometric analysis of phosphorylated GSK3 (Ser-9) normalized to total GSK3. D, immunoblots of mdMSC treated with KU0063794 and then stimulated with insulin (50 nM) for 60 min.</p>

Gegevens van [ J Biol Chem , 2011 , 286, 39450-6 ]

<p>mTORC2-mediated stretch-induced SGK-1 phosphorylation. SMCs infected with Ad-SGK-1 were pretreated with PPP (10 μmol/L), rapamycin (100 nmol/L),or Ku-0063794 (10 μmol/L) for 30 minutes and then were subjected to stretch or IGF-1 (10 ng/mL) for 30 minutes.</p><div><div> </div></div><p> </p>

Gegevens van [ Circ Res , 2010 , 107, 1265-1274 ]

<p>For MTT assays, cells (2,000 ~ 5,000 cells/well) were subcultured into 96-well plates according to their growth properties. Cell proliferation was assayed at 72 hr after treatment of KU-0063794 by adding 20 μl of 5 mg/ml 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) solution per 100 μl of growth medium. After incubating for 3-4 h at 37°C, the media were removed and 150 µl/well of MTT solvent (either absolute DMSO or isopropanol containing 4 μM HCl and 0.1% Nonidet-40) was added to dissolve the formazan. The absorbance of each well was measured by ELx808 (BioTek, Winooski, VT) or Wallac Victor2 (Perkin-Elmer Life Sciences, Boston, MA) Microplate Reader. Viable cells are presented as percent of control, vehicle-treated cells.</p><div><div> </div></div><p> </p>

, , Dr. Yong-Weon Yi from Georgetown University Medical Center

Selleck's KU-0063794 Is geciteerd door 84 Publicaties

SLAP controls mTORC2 integrity via UBE3C-mediated non-degradative mLST8 ubiquitination to suppress colorectal tumorigenesis [ Cell Death Differ, 2026, 33(5):1020-1035] PubMed: 41398047
Molecular control of PDPNhi macrophage subset induction by ADAP as a host defense in sepsis [ JCI Insight, 2025, e186456] PubMed: 39903516
mTORC2-driven chromatin cGAS mediates chemoresistance through epigenetic reprogramming in colorectal cancer [ Nat Cell Biol, 2024, 10.1038/s41556-024-01473-0] PubMed: 39080411
Exploitation of the fibrinolytic system by B-cell acute lymphoblastic leukemia and its therapeutic targeting [ Nat Commun, 2024, 15(1):10059] PubMed: 39567540
mTORC1 regulates cell survival under glucose starvation through 4EBP1/2-mediated translational reprogramming of fatty acid metabolism [ Nat Commun, 2024, 15(1):4083] PubMed: 38744825
Resistin secreted by porcine alveolar macrophages leads to endothelial cell dysfunction during Haemophilus parasuis infection [ Virulence, 2023, 14(1):2171636] PubMed: 36694280
Mechanosensitive mTORC2 independently coordinates leading and trailing edge polarity programs during neutrophil migration [ Mol Biol Cell, 2023, 34(5):ar35] PubMed: 36857159
Combined Mcl-1 and YAP1/TAZ inhibition for treatment of metastatic uveal melanoma [ Melanoma Res, 2023, 10.1097/CMR.0000000000000911] PubMed: 37467061
Targeting the REF1/STAT3 axis to treat tuberous sclerosis [ Cardiff University, 2023, ] PubMed: None
Aggresome assembly at the centrosome is driven by CP110-CEP97-CEP290 and centriolar satellites [ Nat Cell Biol, 2022, 24(4):483-496] PubMed: 35411088

RETOURBELEID
Selleck Chemical's onvoorwaardelijke retourbeleid zorgt voor een soepele online winkelervaring voor onze klanten. Als u op enigerlei wijze ontevreden bent met uw aankoop, kunt u elk artikel(en) binnen 7 dagen na ontvangst retourneren. In geval van problemen met de productkwaliteit, zowel protocolgerelateerde als productgerelateerde problemen, kunt u elk artikel(en) binnen 365 dagen na de oorspronkelijke aankoopdatum retourneren. Volg de onderstaande instructies bij het retourneren van producten.

VERZENDING EN OPSLAG
Selleck producten worden bij kamertemperatuur vervoerd. Als u het product op kamertemperatuur ontvangt, wees dan gerust, de Selleck kwaliteitsinspectieafdeling heeft experimenten uitgevoerd om te controleren of de normale temperatuurplaatsing van één maand de biologische activiteit van poederproducten niet beïnvloedt. Na ontvangst dient u het product op te slaan volgens de vereisten beschreven in het gegevensblad. De meeste Selleck producten zijn stabiel onder de aanbevolen omstandigheden.

NIET VOOR HUMANE, VETERINAIRE DIAGNOSTISCHE OF THERAPEUTISCHE DOELEINDEN.